GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (LTS:0YAY) » Definitions » E10

Vitrolife AB (LTS:0YAY) E10 : kr0.10 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Vitrolife AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vitrolife AB's adjusted earnings per share data for the three months ended in Dec. 2024 was kr1.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr0.10 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was -65.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Vitrolife AB was 13.50% per year. The lowest was -65.70% per year. And the median was 8.55% per year.

As of today (2025-03-04), Vitrolife AB's current stock price is kr195.85. Vitrolife AB's E10 for the quarter that ended in Dec. 2024 was kr0.10. Vitrolife AB's Shiller PE Ratio of today is 1,958.50.

During the past 13 years, the highest Shiller PE Ratio of Vitrolife AB was 8000.00. The lowest was 42.32. And the median was 96.68.


Vitrolife AB E10 Historical Data

The historical data trend for Vitrolife AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB E10 Chart

Vitrolife AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.13 2.44 2.73 -0.14 0.10

Vitrolife AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.14 -0.08 -0.01 0.03 0.10

Competitive Comparison of Vitrolife AB's E10

For the Medical Devices subindustry, Vitrolife AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Shiller PE Ratio falls into.



Vitrolife AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vitrolife AB's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.02/132.9872*132.9872
=1.020

Current CPI (Dec. 2024) = 132.9872.

Vitrolife AB Quarterly Data

per share eps CPI Adj_EPS
201503 0.322 99.950 0.428
201506 0.354 99.995 0.471
201509 0.482 100.228 0.640
201512 0.526 100.276 0.698
201603 0.354 100.751 0.467
201606 0.442 101.019 0.582
201609 0.410 101.138 0.539
201612 0.548 102.022 0.714
201703 0.546 102.022 0.712
201706 0.660 102.752 0.854
201709 0.600 103.279 0.773
201712 0.630 103.793 0.807
201803 0.660 103.962 0.844
201806 0.730 104.875 0.926
201809 0.690 105.679 0.868
201812 0.770 105.912 0.967
201903 0.790 105.886 0.992
201906 0.870 106.742 1.084
201909 0.980 107.214 1.216
201912 0.890 107.766 1.098
202003 0.740 106.563 0.923
202006 0.110 107.498 0.136
202009 0.810 107.635 1.001
202012 0.990 108.296 1.216
202103 1.090 108.360 1.338
202106 0.790 108.928 0.964
202109 0.890 110.338 1.073
202112 0.200 112.486 0.236
202203 0.600 114.825 0.695
202206 0.960 118.384 1.078
202209 0.800 122.296 0.870
202212 0.550 126.365 0.579
202303 0.740 127.042 0.775
202306 0.780 129.407 0.802
202309 0.900 130.224 0.919
202312 -30.860 131.912 -31.112
202403 0.850 132.205 0.855
202406 1.060 132.716 1.062
202409 0.850 132.304 0.854
202412 1.020 132.987 1.020

Add all the adjusted EPS together and divide 10 will get our e10.


Vitrolife AB  (LTS:0YAY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Vitrolife AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=195.85/0.10
=1,958.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Vitrolife AB was 8000.00. The lowest was 42.32. And the median was 96.68.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Vitrolife AB E10 Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

Vitrolife AB Headlines

No Headlines